TY - JOUR T1 - Human papillomavirus (HPV) prevalence in relation with cervical cytology in Bengali population of India JF - medRxiv DO - 10.1101/2020.06.01.20119628 SP - 2020.06.01.20119628 AU - Puja Banerjee AU - Arghya Bondhopadhyay AU - Bibek Mohan Rakshit AU - Amitava Pal AU - Anupam Basu Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/02/2020.06.01.20119628.abstract N2 - Background Human papillomavirus (HPV) is one of the major infectious agents of cervical cancer. Papanicolaou (pap) smear study is generally carried out to screen the initial cervical condition and consequently specific PCR based study is carried out to recognize the different types of HPV. In the present study, we would like to screen the frequency of HPV infection in the women with normal and abnormal cervical discharges.Methods In our study, 216 subjects were recruited. Cervical cytology was done by Pap smear test. Nested PCR was carried out using MY09/11 and GP 5+/6+ primers to screen HPV infection.Result and conclusion A significant co-relation between HPV infection and early sexual intercourse was observed. We found a higher HPV prevalence in the age group below 29 years(35.48%). 85.71% SCC patients were positive for HPV infection, 80% HSIL patients were positive for HPV infection, 75% LSIL patients were positive for HPV infection; 66.7% ASCUS patients were positive for HPV infection. 50% ASC-H patients were positive for HPV infection. HPV positive was found in 22.22% of the subjects, among them 16.75% show normal cytology (NILM).Competing Interest StatementThe authors have declared no competing interest.Funding Statementin houseAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:institutional ethics committee, Burdwan UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesas per requestSCCSquamous cell carcinomaHSILHigh Grade Squamous Intra-epithelial LesionLSILLow-Grade Squamous Intra-epithelial LesionASCUSAtypical squamous cells of undetermined significanceASC-HAtypical Squamous Cells, Cannot Rule Out High-Grade Squamous Intra-epithelial LesionNILMNegative for Intraepithelial Lesion or Malignancy ER -